Bone Biologics Corp (BBLG)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.10M
Last updated: Nov 17, 2026 at 4:10 PM ET
Bone Biologics Corp (BBLG) Stock Chart
Bone Biologics (BBLG) has a latest price of $0.29 on Nov 17, 2026, 87.8% below its 52-week high of $2.39. Its price fell 81.8% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 61.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $37,469.98 in Nov 2018 and its lowest $0.38 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BBLG with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BBLG.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 54.4%, and over 6 months it fell 76.8%. The month-end price fell 98.5% over the 3 years through Oct 2026, a compound annual decline of 75.3%.
| Period | Change |
|---|---|
| 1 month | -28.9% |
| 3 months | -54.4% |
| 6 months | -76.8% |
| 12 months | -81.8% |
| 12 months, with dividends | -81.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -98.5% | -75.3% |
| 5 years | -100.0% | -86.1% |
| 10 years | -100.0% | -61.4% |
Price by Year
Its best calendar year was 2020, when the price rose 87.5%, and its weakest was 2022, when it fell 94.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.38 | -73.8% |
| 2025 | $1.45 | -74.3% |
| 2024 | $5.64 | -79.2% |
| 2023 | $27.11 | -91.0% |
| 2022 | $302.21 | -94.0% |
| 2021 | $5,072.86 | -53.1% |
| 2020 | $10,808.65 | +87.5% |
Trading Range
The price is 32.7% below its 50-day average of $0.43 and 70.2% below its 200-day average of $0.98.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.29 | |
| 52-week high | $2.39 | -87.8% |
| 52-week low | $0.27 | +9.8% |
| 50-day average | $0.43 | -32.7% |
| 200-day average | $0.98 | -70.2% |
Price Risk
Over 3 years, its largest fall from a peak was 99.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.06 |
| Largest fall, 1 year | -86.2% |
| Largest fall, 3 years | -99.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BBLG
What is BBLG's 1-year price change?
Bone Biologics's price fell 81.8% over the past 12 months. With dividends included, the 12-month total return was -81.8%.
What is BBLG's 5-year price change?
Bone Biologics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 86.1%. These figures leave out dividends.
What is BBLG's 52-week high and low?
Bone Biologics's 52-week high is $2.39 and its 52-week low is $0.27. Its latest price of $0.29 on Nov 17, 2026 is 87.8% below the high.
What is BBLG's beta?
Bone Biologics's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 86.2%.
Is the BBLG chart free?
Yes. Advanced Charting for BBLG is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BBLG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors